Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026)
Achieve Life Sciences (ACHV) posted Amortization of Deferred Charges of $12000.0 for Q1 2026, up 9.09% on a QoQ basis from $11000.0 in Q4 2025, and down 14.29% year-over-year from $14000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Achieve Life Sciences' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $12000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 14.29% year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50000.0 (changed N/A YoY) and the FY2025 annual result came in at $52000.0, up 126.09% from the prior year.
- Amortization of Deferred Charges was $12000.0 for Q1 2026 at Achieve Life Sciences, up from $11000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $14000.0 in Q4 2024 and bottomed at $11000.0 in Q4 2025.
- A 3-year average of $13000.0 and a median of $13500.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2025 — Amortization of Deferred Charges fell 21.43% — and 2026, when it dropped 14.29%.
- Achieve Life Sciences' Amortization of Deferred Charges stood at $14000.0 in 2024, then declined by 21.43% to $11000.0 in 2025, then gained by 9.09% to $12000.0 in 2026.
- Business Quant data shows ACHV's Amortization of Deferred Charges at $12000.0 in Q1 2026, $11000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Achieve Life Sciences | 331.77 Mn | 331.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |